High Signal Intensity Lesions of the Chest in MR Imaging
Jerome Barakos(Sutter Health), Charles B. Higgins(University of California, San Francisco), Robert J. Brescia(Calvary Hospital), Jeffrey J. Brown(The University of Texas MD Anderson Cancer Center)
Cited by 33
Related Papers
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|741
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
|The Lancet Neurology|2010|696
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
|JAMA Neurology|2021|602